Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredrik Erlandsson

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cytometry|January 5, 2002
Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nucleiCarolina Wählby, Fredrik Erlandsson, Ewert Bengtsson, et al.
Experimental Cell Research|April 9, 2005
Single cell analysis of G1 check points-the relationship between the restriction point and phosphorylation of pRbHanna-Stina Martinsson, Maria Starborg, Fredrik Erlandsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2015
Validation of the IntelliCap® system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drugErik Söderlind, Bertil Abrahamsson, Fredrik Erlandsson, et al.
Anticancer Research|April 20, 2006
Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancerLiselotte Dahlgren, Fredrik Erlandsson, David Lindquist, et al.
International Journal of Cancer|February 6, 2003
Abnormal expression pattern of cyclin E in tumour cellsFredrik Erlandsson, Carolina Wählby, Susanna Ekholm-Reed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 2020
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized TrialAustin G Stack, Nalina Dronamraju, Joanna Parkinson, et al.
Pharmacology Research & Perspectives|May 20, 2022
Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non-Asian participantsSusanne Johansson, David Han, Thomas Hunt, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2021
In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug TransportersV Sashi Gopaul, Anna Vildhede, Tommy B Andersson, et al.
Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2020
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ StudyAustin G Stack, David Han, Ronald Goldwater, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cytometry|January 5, 2002
Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nucleiCarolina Wählby, Fredrik Erlandsson, Ewert Bengtsson, et al.
Experimental Cell Research|April 9, 2005
Single cell analysis of G1 check points-the relationship between the restriction point and phosphorylation of pRbHanna-Stina Martinsson, Maria Starborg, Fredrik Erlandsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2015
Validation of the IntelliCap® system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drugErik Söderlind, Bertil Abrahamsson, Fredrik Erlandsson, et al.
Anticancer Research|April 20, 2006
Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancerLiselotte Dahlgren, Fredrik Erlandsson, David Lindquist, et al.
International Journal of Cancer|February 6, 2003
Abnormal expression pattern of cyclin E in tumour cellsFredrik Erlandsson, Carolina Wählby, Susanna Ekholm-Reed, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 2020
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized TrialAustin G Stack, Nalina Dronamraju, Joanna Parkinson, et al.
Pharmacology Research & Perspectives|May 20, 2022
Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non-Asian participantsSusanne Johansson, David Han, Thomas Hunt, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2021
In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug TransportersV Sashi Gopaul, Anna Vildhede, Tommy B Andersson, et al.
Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2020
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ StudyAustin G Stack, David Han, Ronald Goldwater, et al.
Pageof 3